TrialThe Lancet. Oncology2017

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.

Justin Guinney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.